Advertisement CoDa receives $6m credit facility from Square 1 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CoDa receives $6m credit facility from Square 1

Square 1 Bank, banking partner to the venture capital community, is providing $6m credit facility to CoDa Therapeutics.

According to the company, the funding comes on the heels of a recent $19m fundraising that was completed in April.

CoDa develops and commerciales therapeutics for wound care, inflammation and tissue repair based on a new platform technology,’Gap Junction Modulation.’

Currently, the company is working on a drug therapy for proper healing of wounds like venous leg and diabetic foot ulcers.